Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia

Moyamoya disease (MMD) is caused by stenosis or occlusion of internal carotid artery in brain, thereby reducing its blood supply. To augment blood flow, brain develops abnormal anastomotic vessels with deranged carbon dioxide reactivity and tendency to bleed. Moyamoya syndrome (MMS) is the name give...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Parmod K. Bithal, Ravees Jan, Ved P. Pandey, Parvaiz Ahmad
Formato:	article
Lenguaje:	EN
Publicado:	Thieme Medical and Scientific Publishers Pvt. Ltd. 2021
Materias:	moyamoya syndrome sickle cell anemia normovolemia normocapnia normothermia Anesthesiology RD78.3-87.3
Acceso en línea:	https://doaj.org/article/7310ccbd2f1a498ab2780665f120afd3
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:7310ccbd2f1a498ab2780665f120afd3
record_format	dspace
spelling	oai:doaj.org-article:7310ccbd2f1a498ab2780665f120afd32021-11-14T23:32:30ZAnesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia2348-05482348-926X10.1055/s-0041-1739349https://doaj.org/article/7310ccbd2f1a498ab2780665f120afd32021-11-01T00:00:00Zhttp://www.thieme-connect.de/DOI/DOI?10.1055/s-0041-1739349https://doaj.org/toc/2348-0548https://doaj.org/toc/2348-926XMoyamoya disease (MMD) is caused by stenosis or occlusion of internal carotid artery in brain, thereby reducing its blood supply. To augment blood flow, brain develops abnormal anastomotic vessels with deranged carbon dioxide reactivity and tendency to bleed. Moyamoya syndrome (MMS) is the name given to MMD when the latter results from secondary to some associated disease. Occurrence of MMS secondary to sickle cell anemia (SCA) presents unique challenges to neuroanesthesiologists. Management of various physiological parameters for cerebral revascularization surgery for MMD under general anesthesia necessitates vigilant and balanced control of various physiological variables, as the manipulation of a particular physiological variable for one pathology may adversely impact the same physiological variable for the associated disease, which will result in poor outcome of the patient. Therefore, optimum outcome of MMS is determined by a watchful balancing of various physiological parameters under anesthesia.Parmod K. BithalRavees JanVed P. PandeyParvaiz AhmadThieme Medical and Scientific Publishers Pvt. Ltd.articlemoyamoya syndromesickle cell anemianormovolemianormocapnianormothermiaAnesthesiologyRD78.3-87.3ENJournal of Neuroanaesthesiology and Critical Care (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	moyamoya syndrome sickle cell anemia normovolemia normocapnia normothermia Anesthesiology RD78.3-87.3
spellingShingle	moyamoya syndrome sickle cell anemia normovolemia normocapnia normothermia Anesthesiology RD78.3-87.3 Parmod K. Bithal Ravees Jan Ved P. Pandey Parvaiz Ahmad Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
description	Moyamoya disease (MMD) is caused by stenosis or occlusion of internal carotid artery in brain, thereby reducing its blood supply. To augment blood flow, brain develops abnormal anastomotic vessels with deranged carbon dioxide reactivity and tendency to bleed. Moyamoya syndrome (MMS) is the name given to MMD when the latter results from secondary to some associated disease. Occurrence of MMS secondary to sickle cell anemia (SCA) presents unique challenges to neuroanesthesiologists. Management of various physiological parameters for cerebral revascularization surgery for MMD under general anesthesia necessitates vigilant and balanced control of various physiological variables, as the manipulation of a particular physiological variable for one pathology may adversely impact the same physiological variable for the associated disease, which will result in poor outcome of the patient. Therefore, optimum outcome of MMS is determined by a watchful balancing of various physiological parameters under anesthesia.
format	article
author	Parmod K. Bithal Ravees Jan Ved P. Pandey Parvaiz Ahmad
author_facet	Parmod K. Bithal Ravees Jan Ved P. Pandey Parvaiz Ahmad
author_sort	Parmod K. Bithal
title	Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
title_short	Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
title_full	Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
title_fullStr	Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
title_full_unstemmed	Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia
title_sort	anesthetic management of moyamoya syndrome secondary to sickle cell anemia
publisher	Thieme Medical and Scientific Publishers Pvt. Ltd.
publishDate	2021
url	https://doaj.org/article/7310ccbd2f1a498ab2780665f120afd3
work_keys_str_mv	AT parmodkbithal anestheticmanagementofmoyamoyasyndromesecondarytosicklecellanemia AT raveesjan anestheticmanagementofmoyamoyasyndromesecondarytosicklecellanemia AT vedppandey anestheticmanagementofmoyamoyasyndromesecondarytosicklecellanemia AT parvaizahmad anestheticmanagementofmoyamoyasyndromesecondarytosicklecellanemia
_version_	1718428992594247680

Anesthetic Management of Moyamoya Syndrome Secondary to Sickle Cell Anemia

Ejemplares similares